Results 121 - 130 of 255 : Previous 9 10 11 12 13 14 15 16 17 Next
Great Data! Now Lets See More Than 12 Patients
Micromet's blinatumomab looks good in a phase 2 trial.
These 7 Stocks Are the Ultimate High-Risk Investments
Biotechnology stocks are volatile investments that have a high-risk, high-reward profile.
11 Incredible Dividend Stocks: Abbott Labs
A health-care conglomerate with growth potential.
Ramping up sales, one month at a time.
This Just In: Upgrades and Downgrades
Credit Suisse disses Dendreon.
6 Smart Stocks for Young Investors
Get your retirement portfolio moving with these great picks.
Dendreon Faces Internet-Fueled Shareholder Uprising
And it's led by a little guy in Kansas.
The Biggest Threat to Dendreon's Future
It isn't CMS.
This Just In: More Upgrades and Downgrades
Collins calls Dendreon a "buy."
Sales Can Quadruple, More to Come
Dendreon is still supply-constrained, but less than before.
Results 121 - 130 of 255 : Previous 9 10 11 12 13 14 15 16 17 Next